as on September 13, 2025 at 1:29 am IST
Day's Low
Day's High
1.07%
Downside
2.94%
Upside
52 Week's Low
52 Week's High
64.04%
Downside
7.35%
Upside
Check Xeris Biopharma Holdings Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$1.2B
EPS (TTM)
-0.01
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-7
Industry PE ratio
0P/B Ratio
0PEG Ratio
0EBITDA
8.4M
Revenue (TTM)
246.0M
Profit Margin
-13.01%
Return On Equity TTM
64961400.00%
Track how Xeris Biopharma Holdings Inc P/E has moved over time to understand its valuation trends.
Xeris Biopharma Holdings Inc in the last 5 years
Lowest (0.00x)
September 13, 2025
Industry (0.00x)
September 13, 2025
Today (-7.00x)
September 13, 2025
Highest (0.00x)
September 13, 2025
Today’s Price to Earnings Ratio: -7.00x
Compare market cap, revenue, PE, and other key metrics of Xeris Biopharma Holdings Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $1.2B | NA | -7 | -13.01% | |
BUY | $61.1B | 280.5% | -505.15 | -12.96% | |
NA | $37.7B | NA | NA | -3.89% | |
BUY | $101.2B | 54.04% | 28.08 | 31.86% | |
BUY | $59.4B | 2.03% | 14.11 | 31.37% |
The Xeris Biopharma Holdings Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Xeris Biopharma Holdings Inc investment value today
Current value as on today
₹2,64,861
Returns
₹1,64,861
(+164.86%)
Returns from Xeris Biopharma Holdings Inc Stock
₹1,59,722 (+159.72%)
Dollar Returns*
₹5,139 (+5.14%)
Based on 12 analysts
91.67%
Buy
8.33%
Hold
0.00%
Sell
Based on 12 analysts, 91.67% of analysts recommend a 'BUY' rating for Xeris Biopharma Holdings Inc. Average target price of $9
Get share price movements and forecasts by analysts on Xeris Biopharma Holdings Inc.
What analysts predicted
16.89%UPSIDE
Target Price
$9
Current Price
$7.48
Analyzed by
12 Analysts
Target
$9.00
Xeris Biopharma Holdings Inc target price $9, a slight upside of 16.89% compared to current price of $7.48. According to 12 analysts rating.
Search interest for Xeris Biopharma Holdings Inc Stock has increased by 38% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:38% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Best in 1 Year
In the last 1 year, XERS has outperformed top 5 stocks with highest market-cap in its industry
Profit Spike
Netprofit is up for the last 2 quarters, -9.22M → -1.92M (in $), with an average increase of 378.2% per quarter
Price Rise
In the last 3 months, XERS stock has moved up by 72.0%
Revenue Rich
Revenue is up for the last 6 quarters, 40.63M → 71.53M (in $), with an average increase of 10.5% per quarter
Best in 3 Years
In the last 3 years, XERS has outperformed top 5 stocks with highest market-cap in its industry
Organisation | Xeris Biopharma Holdings Inc |
Headquarters | 1375 West Fulton Street, Chicago, IL, United States, 60607 |
Industry | Health Technology |
CEO | Mr. John P. Shannon |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Dr. Anh Nguyen M.B.A., M.D. | Chief Medical Officer |
Mr. John P. Shannon | CEO & Director |
Mr. Kevin McCulloch | President & COO |
Ms. Kendal Korte | Senior Vice President of Human Resources |
Ms. Allison Wey | Senior Vice President of Investor Relations & Corporate Communications |
Mr. Brian Conner | SVP of Quality and Chief Compliance & Risk Officer |
Mr. Steven M. Pieper | Chief Financial Officer |
Ms. Beth P. Hecht J.D. | Chief Legal Officer & Corporate Secretary |
Mr. Paul R. Edick J.D. | Senior Advisor |
Xeris Biopharma Holdings Inc share price today is $7.48 as on at the close of the market. Xeris Biopharma Holdings Inc share today touched a day high of $7.7 and a low of $7.4.
Xeris Biopharma Holdings Inc share touched a 52 week high of $8.03 on and a 52 week low of $2.69 on . Xeris Biopharma Holdings Inc stock price today i.e. is closed at $7.48,which is 6.85% down from its 52 week high and 178.07% up from its 52 week low.
Xeris Biopharma Holdings Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Xeris Biopharma Holdings Inc (XERS) shares with as little as ₹88.27 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹882.70 in Xeris Biopharma Holdings Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Xeris Biopharma Holdings Inc share’s latest price of $7.48 as on September 13, 2025 at 1:29 am IST, you will get 1.3369 shares of Xeris Biopharma Holdings Inc. Learn more about
fractional shares .